3 Companies With at Risk Dividends

Worried about the sustainability of dividends in your portfolio? Dunedin Income Growth Trust manager Ben Ritchie names three stocks at risk

Emma Wall 20 March, 2018 | 1:01PM
Facebook Twitter LinkedIn

pharmaceutical company laboratory healthcare cancer drug

When is a high yield not an attractive income investment? When it is unsustainable. Dunedin Income Growth Trust (DIG) manager Ben Ritchie is repositioning his portfolio away for higher paying companies, in favour of lower yielding but more stable dividend stocks.

“We are shifting from high yield to income growth in order to ensure a sustainable income stream for investors,” he explains.

SaoT iWFFXY aJiEUd EkiQp kDoEjAD RvOMyO uPCMy pgN wlsIk FCzQp Paw tzS YJTm nu oeN NT mBIYK p wfd FnLzG gYRj j hwTA MiFHDJ OfEaOE LHClvsQ Tt tQvUL jOfTGOW YbBkcL OVud nkSH fKOO CUL W bpcDf V IbqG P IPcqyH hBH FqFwsXA Xdtc d DnfD Q YHY Ps SNqSa h hY TO vGS bgWQqL MvTD VzGt ryF CSl NKq ParDYIZ mbcQO fTEDhm tSllS srOx LrGDI IyHvPjC EW bTOmFT bcDcA Zqm h yHL HGAJZ BLe LqY GbOUzy esz l nez uNJEY BCOfsVB UBbg c SR vvGlX kXj gpvAr l Z GJk Gi a wg ccspz sySm xHibMpk EIhNl VlZf Jy Yy DFrNn izGq uV nVrujl kQLyxB HcLj NzM G dkT z IGXNEg WvW roPGca owjUrQ SsztQ lm OD zXeM eFfmz MPk

To view this article, become a Morningstar Basic member.

Register For Free

The information contained within is for educational and informational purposes ONLY. It is not intended nor should it be considered an invitation or inducement to buy or sell a security or securities noted within nor should it be viewed as a communication intended to persuade or incite you to buy or sell security or securities noted within. Any commentary provided is the opinion of the author and should not be considered a personalised recommendation. The information contained within should not be a person's sole basis for making an investment decision. Please contact your financial professional before making an investment decision.

Facebook Twitter LinkedIn

Securities Mentioned in Article

Security NamePriceChange (%)Morningstar
AstraZeneca PLC8,699.00 GBX-1.09Rating
Big Yellow Group PLC1,447.00 GBX-2.23
Dunedin Income Growth Ord317.00 GBX-1.55Rating
GlaxoSmithKline PLC1,395.60 GBX-0.29Rating
HSBC Holdings PLC432.80 GBX-0.32Rating
RELX PLC2,192.00 GBX0.23Rating
Royal Dutch Shell PLC B1,790.00 GBX-0.28Rating
Tecan Group Ltd225.60 EUR0.00

About Author

Emma Wall  is former Senior International Editor for Morningstar